Shiela is an Associate at the HITAP International Unit. She holds a doctoral degree in Microbiology and currently leads antimicrobial resistance (AMR)-related projects at HITAP, in collaboration with international partners such as the University of Oxford, City St George’s University of London, and global organizations including the World Health Or

Jarawee Sukmanee is a researcher at the Health Intervention and Technology Assessment Program Foundation (HITAP). With a background as a medical doctor and epidemiologist, she applies advanced analytical techniques to evaluate the cost-effectiveness of health interventions. She plays a key role in generating evidence to support national policy deci

Pritaporn Kingkaew has been a researcher at HITAP since 2007. She graduated from a joint programme between Srinakharinwirot University, Thailand and the University of Nottingham, UK in 2007 with a Bachelor’s degree in Pharmacy. In 2009, she was awarded the HITAP scholarship to pursue a Master’s degree in Health Economics from the University of York

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.

Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo

The Post Graduate Institute of Medical Education and Research (PGIMER) requested HITAP to provide technical support to a national workshop on the use of economic evaluation analyses and research for decision making in healthcare in India. The workshop ran for four days and covered the differen

India is setting up a priority setting unit called the Medical Technology Assessment Board (MTAB) under the Department of Health Research (DHR) in the Ministry of Health and Family Welfare (MoHFW), Government of India. The International Decision Support Initiative (iDSI) is working with DHR in its e

Bhutan is a rapidly growing economy that is transitioning from international donor support. As such, the country is looking for ways to ensure that they continue to provide the adequate services and support for their population in a rational and sustainable manner. Bhutan has begun using health tech

The Ministry of Health (MoH), Bhutan has developed a health technology assessment (HTA) program in Bhutan since 2013 and has continued its efforts to build HTA capacity and maintain its momentum. This year, the MoH shows interest and is seeking support on: • Cost-effectiveness threshold led by th

This course was organised at the request of Prof. Rakesh Aggarwal, the Director of JIPMER and Prof. Gagandeep Kang, the Executive Director of THSTI and Professor at the Christian Medical College (CMC) in Vellore, India. The main objective of the course was to build technical capacity of stakeholders